Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Cancer Trials Ireland
Screening/Baseline 1. Routine blood tests (Haematology and Biochemistry) as per hospital practice 2. Research serum sample for proteomic studies (10ml blood sample) 3. Routine pre-treatment CT but with formal RECIST/WHO measurements of tumour size 2 months Post Commencement of Treatment with erlotinib: Routine CT with RECIST/WHO assessment 4 months Post Commencement of Treatment with erlotinib: Routine CT with RECIST/WHO assessment 1 year Post Commencement of Treatment with erlotinib (as per current standard of care): Routine CT with RECIST/WHO assessment Response Assessment: CT scans at baseline, at 2 and 4 months post commencement of therapy and one year after treatment with erlotinib will be analyzed with the emphasis on identification of disease progression. Follow Up: Subsequent follow-up as per routine.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
